Pyxis Oncology (PYXS) Other Non-Current Assets (2020 - 2022)
Pyxis Oncology (PYXS) reported Other Non-Current Assets of $1.5 million for Q3 2022, up 1250.46% year-over-year from $109000.0 in Q3 2021, and little changed on a QoQ basis from $1.5 million in Q2 2022.
Pyxis Oncology (PYXS) has 3 years of Other Non-Current Assets data on file, last reported at $1.5 million in Q3 2022.
- Quarterly Other Non-Current Assets rose 1250.46% year-over-year to $1.5 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $1.5 million (up 1250.46% YoY) and the FY2021 annual result came in at $109000.0, changed 0.0% from the prior year.
- Other Non-Current Assets steadied at $1.5 million in Q3 2022 per PYXS's latest filing, from $1.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.5 million in Q2 2022 and bottomed at $108000.0 in Q2 2021.
- The 3-year median for Other Non-Current Assets is $109000.0 (2020), against an average of $492125.0.
- The widest annual swing landed in 2021, when Other Non-Current Assets changed 0.0%; it then jumped 1262.96% in 2022.
- Tracing PYXS's Other Non-Current Assets over 3 years: stood at $109000.0 in 2020, then changed by 0.0% to $109000.0 in 2021, then soared by 1250.46% to $1.5 million in 2022.
- Per Business Quant, the three latest PYXS Other Non-Current Assets figures stand at $1.5 million (Q3 2022), $1.5 million (Q2 2022), and $449000.0 (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.13 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Pyxis Oncology | 120.87 Mn | 103.97 Mn | 8.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 449,000.00 |
| Dec 31, 2021 | 109,000.00 |
| Sep 30, 2021 | 109,000.00 |
| Jun 30, 2021 | 108,000.00 |
| Mar 31, 2021 | 109,000.00 |
| Dec 31, 2020 | 109,000.00 |